A Retrospective Cross-Sectional Study Assessing Self-Reported Adverse Events following Immunization (AEFI) of the COVID-19 Vaccine in Bangladesh

Background: The Oxford–AstraZeneca vaccine (Covishield) was the first to be introduced in Bangladesh to fight the ongoing global COVID-19 pandemic. As this vaccine had shown some side-effects in its clinical trial, we aimed to conduct a study assessing short-term adverse events following immunizatio...

Full description

Bibliographic Details
Main Authors: Arifa Sultana, Saimon Shahriar, Md. Rafat Tahsin, Sabiha Rahman Mim, Kazi Rubiya Fatema, Ananya Saha, Fahmida Yesmin, Nasiba Binte Bahar, Mithun Samodder, Md. Ariful Haque Mamun, Md. Aknur Rahman, Sonia Ferdousy, Tahmina Akter, Fahima Aktar, Md. Ruhul Kuddus, Md. Mustafizur Rahman, Md. Moklesur Rahman Sarker, Sultan Mehtap Büyüker, Jakir Ahmed Chowdhury, Abu Asad Chowdhury, Shaila Kabir, Md. Akter Hossain, Md. Shah Amran
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/9/10/1090